NCT06918912
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06918912
Title Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure (LORELY)
Acronym LORELY
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Clinico Humanitas
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.